Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Again, never said they were cancelled. I said a phase 3 trial has not been started. Show me the documents that say they are financed. I have been hearing that sh*t for months. I know what I've been told, same as you, but until I can see it in writing, or until it is in a PR, I will not believe it. I have been lied to, too many times. I watch the stock I invested 75% of my livelyhood in, tank because of a CEO, who can't even handle a simple PR campaign. And now, it's going to take more than a regular PR campaign to recover this stock.
I have said numerous times it will not recover without revenue or solid potential revenue news. It should not be this way, but with the horrible PRs earlier, lack of PRs, regular PRs of company news will not get retail investors to trade IMUN. The proof is in the numbers and stock price. There is a fix as LA has said and I agree: need revenue related news. The only disagreement I have is that it's an "easy fix". You need revenue to report revenue. So far since both these companies conception, nor, IMUN or Cytocom have reported any revenue. We are in the dark on Cytocom (except tax documents), And we have received nothing about the Fidson deal. So here we will sit and wait, and the stock will stay here within .016-.025 And will not recover UNLESS we get revenue based PR to stimulate the retail trading we so desperately need.
The fix is only easy if you can report a PR with money in it. If Noreen does not have that ability, then it can't be put in a PR. Which, the way I look at it, it's only easy if you can report revenue. It has been many years IMUN shareholders have been waiting, and now retail is waiting before they will invest. Whereas before, they invested on faith, optimism, belief in the drug, or whatever the reason. Now our trade volume and price (even when great news is released). You can disagree with my analogy and the way I look at things Dwarren, but the numbers, stock price and what the stock does on the release of non revenue news, dies not lie.
I have agreed with LA and you on many things. No, I do not think the fix is that easy. We have had some great news lately, and we are still under .02. I have said and agreed numerous times that we need news that relates to revenue. Is that an easy fix? It is if you are receiving revenue, but we have been waiting for many years for the announcement if revenue. We had one, and then apparently that fell through, and now on to Fidson. What doesn't add up is your picking and choosing my words to try to create things that are not true. Noreen and Gina have led to the path of non retail trading because of many PR mistakes, and lack of PR. This stock will only jump on the announcement of news that relates to some sort of revenue. Retail traders are not going to start investing, until they see money or a solid chance of money. I am mad and frustrated. This stock should be trading at a very minimum of .04-.06. It was trading at that with only hopes and optimism last year. But look at us now. More news this year than any prior year, and IMUN IS BELOW .02. Why, well LA and I have already beat that horse. I want news like everyone. It has been to many years, no one at thus price is in the green, and Noreen and Gina need to be accountable to the investors. We need news that relates to MONEY. A finance deal for a phase 3 trial, a buyout offer, a Fidson agreement...something that says Cytocom/IMUN has revenue, or what they are doing will lead to revenue. I'm in deep, which I'm sure each and every shareholder is. Bottom line we need news/PR with something tied to REVENUE. We all know Noreen reads IHUB, I hope that all these posts help her to realize how frustrated the stockholders are with the stick price where it's at
GM all. I never ever used the word cancelled. You said Dwarren: how Do I know that the phase 3 has not been started yet. My response was: I was told there has not been a phase 3 trial started yet. I verified that with the FDA website. There is no registration by Cytocom/IMUN that says They have started a phase 3 trial. I'm not sure what you think doesn't add up? The FDA is not accurate, or there has been a secret unregistered phase 3 trial that has started. It doesnt matter, when Cytocom or IMUN starts a phase 3 trial they must submit to the FDA within 21 days of accepting the first patient. So even before any phase 3 trial starts, it will be on the FDA a month(s) before it even starts. The large amount of people takes(on a phase 3), quite a bit of time to select.
Because it doesn't matter, I am not relying on what people tell me, only official communications and filed documents for my responses. You have your answer. There are no phase 3 trials registered with the FDA.
The really revelant LDN trial was done by Stanford for fibromyalgia. It says the trial was completed.
I the trial was withdrawn.
And there is no Cytocom or IMUN trial filed with the FDA at this time.
Does it really matter? I am lied to 80% of the time, that's why I only rely on official things like the FDA, SEC, IRS, STATE government documents and the such.
Great site, great info...Sounds like another wasted PR opportunity by Noreen.
As a Cytocom stockholder, I asked the question, also trials must be registered with the FDA.
FROM THE FDA website: "The responsible party (that is, the sponsor or designated PI) for an ACT must submit the required clinical trial information no later than 21 days after enrollment of first participant"
In any case, whether buyout, or NASDAQ, NYSE listing, both cases are a win for both companies, but someone. Cough cough, needs to get off their ass, get some money, and get this phase 3 ball rolling.
No, they haven't started them. They need capital. Don't worry, that would probably be the one thing Noreen would never want to hide. Once approval for phase 3 starts, it will out to let big pharma know it won't be long until we make their Chrone's meds obsolete. Big Pharma will probably be getting Buyout offers prepared, so once the favorable phase 3 trials are announced they will swooping in with offers for buyout. A phase 3 trial will also shoot IMUN stock up
OTCX is walking down the ask again. This should be illegal,you know these are not legitimate borrowed shares. These are counterfeit shares by offshore MMs
And just did it again. As*holes
Yup, and just sold back to themselves, a small amount to drop it back down to .0171. MM games again.
They have incredible amounts to lose, thats why the phase 3 is more important for Cytocom, who owns the US patents for LDN. Anyone, which is many, many IMUN holders are invested in Cytocom. The hope, is a buyout. Without a phase 3, and FDA approval, big Pharma is not doing anything right now. Big Pharma needs to see a phase 3 with FDA approval, not some 5 year old phase 2 trial. For now, LDN is all hype, with no current full blown phase studies. There have been many over the last few years(I posted links to many), but all are small, and done on their own (no FDA or Euro involvement).
Again, we ask the question: why has it been so many years between a positive phase 1 &2 study? This is unheard of for a drug of this potential. So many things just do not make sense and Noreen will not tell the investors anything.
The exposure is good, but the Info is old. These same studies (Jill Smiths 2013) have been getting thrown around for years. This was an AIDS conference, if these 5 year old studies are so great (which they were), why has there been no further trials in 5 years??? Again, NO one has any answers to any of the questions I brought up yesterday.
Where is the Fidson Revenue?
Why do we have an updated Fidson sight with no mention of this incredible drug that is going to be made available to the Nigerian people.
Why is IMUN not at least throwing an update to the investors out there: "still finalizing the contracts, negotiating price". Something about revenue or potential revenue.
When did Jill Smith do the phase 2 trials...4-5 years ago? Why so long for a phase 3, when trials 1&2 we're so positive?
There are many, many, many more questions, and no transparency, no answers.
Like Zoid said, any information anyone has, it would be nice to share, we are all in the dark, except Hopeful, who has been absent, and won't share the Info NOREEN gave on their last few phone calls.
Dwarren, ever get Hopeful to answer your questions?
If you look at the trade data, most of the trading volume has been at .016 and below. Someone is pulling an MM play and buying a small block at .0175 to try to get the price up. Good luck to you. I did this for months, but finally realized I wasn't doing any good and just putting myself further in the hole. I commend whoever is buying a little higher. Good luck.
I have been told he has and is an IMUN advisor, but doesn't want his name released. I wonder why????? Would you at this time? I am sure Vincent does not want to risk a stain on his accomplishments, and like the retail investors, I am co evident, if and when you see FDA news, phase 3 news, and revenue news, he will finally allow his name to be associated with IMUN. That is my prediction. Remember that prediction.
Definitely, but we will see where it closes at, then tomorrow, the next day, the next week, the next month, or however it takes to get news of revenue. I have had more faith in this company than most, but after being lied to time after time (like the retail investors), I have lost faith in anything Noreen says. The only thing that will convince most current and future inventors is revenue.
Exactly. But no money, no revenue, no revenue PRs = No stock value. If Noreen had put out regular PRs telling the story, the stock would have run just like most others with a good story, but with incompetence, and a general lack of give a sh*t, here we are, stuck At a penny and a half, with nothing that will stimulate our stock price, except news of revenue. Easy fix LA??? If there is no revenue, there is no PR about revenue. Since 2012, it has been talk about deal after deal in Africa. PR about contracts, revenue, but before IMUN sees a dime, we are changing distributors again. IMUN has not received one dime from Africa, it's been 8 months since the talk of Fidson. 5-6 months since it was official. Since, nothing. No updates, Fidson updates it's website. No thing about any deals with IMUN to distribute a greatly needed drug to its people. Does anyone not find this strange????
Where is the revenue?
Where is news with the FDA?
Where is the news with Fidson?
Where is the phase 3 trial news?
Where is the news about Cytocom? You remember them? The ones who hold all the US patents for LDN and MENK.
Where is the phase 3 trials with Cytocom?
IMUN is broke, but the agreementbetween the 2 says until bought out or financed and listed, Cytocom is funded by IMUN. We here is the updates with what's going on with them???
Imun shareholders (until such time Ctovom can find itself) are funding Cytocom for a 10% stake. So what's going on with them? IMUN shareholders have been and still are funding Cytocom, at least as far as we know.
There is only one thing that will stimulate retail trading SHOW THEM THE MONEY NOREEN!!!!
NO MONEY, NO REVENUE, NO RETAIL TRADING, NO STOCK VALUE. THE NUMBERS SPEAK FOR THEMSELVES. NOREEN AND GINA HAVE DESTROYED ANY FUTURE CHANCE OF HONEST RETAIL TRADING WITHOUT REVENUE...SO FAR FOR 7 YEARS, ITS BEEN PROMISES OR DEALS AND AGREEMENTS. BUT NOT PENNY OF REVENUE.
WE NEED REAL REVENUE, NOT NOREENS CONTINUED BULLS**T OF THINGS THAT NEVER COME TO BE.
I REALLY FEEL BAD FOR THE PEOPLE WHO GAVE NOREEN MONEY AT 1-8 DOLLARS OVER THE YEARS. THEY ARE IN DEEP.
DID anyone else notice that ghe OTC now has our outstanding shares over 402+ now. Who bought, or was given the 7 million shares??? Did anyone here anything on this?
Agreed. This stock will never trade where it should anymore. Noreen and Gina have destroyed the faith of new retail investors. News like this should have rocked the needle, at least a .03 jump. We should be at .04-.06. Today's news should have sparked retail trading and a jump to .08. Unfortunately Noreen and Gina have damaged the retail traders faith in this stock so badly, her we are on a good trading Tuesday, with incredible news and where is our stock? Down instead of up. LA, you keep saying it's an easy fix, but as the last few news releases have shown, the fix is not as easy as you say.
The only thing that will repair the extensive damage Noreen has done to the retail trading and stock value is MONEY, MONE, MONEY. That's it. Without some sort of revenue announcement, our stock will stay in the toilet. We need a credible paper trail of revenue. FDA approvals, phase 3 trials, Cytocom updates on a revenue stream, Africa commitments or money. We have said this before, and the stock price continuing to drop on good news is proof in the pudding of what's going on. Everyone is going to have to wait until ACTUAL REVENUE or almost guaranteed revenue (like an FDA approval), is announced.
Great news, but at this point, too much damage has been done with lack of/confusing prior PRs. It is our reality now. There is no easy fix anymore. You can disagree with me, but the stock price reflects the reality, not mine or anyone's opinion. No retail investors will touch us anymore, UNLESS there revenue coming in. It has been too many years of promised deals in Africa, without 1 cent of revenue to this day.
Sorry, been off ihub for a few days. Digging in and submitting requests takes much time. My presence here will be limited while I am digging in and looking/requesting information. A whole week, and still no PR releases about Amsterdam, nothing on Fidson, nothing on Cytocom.....such bulls**t. I think, since the board is also standing by and doing nothing, there must be some accountability to them also. I guess I should expand my research and digging to them also. Anyway GLTA
Not buying it...not one bit. Broken promises, lies....Again the question is why? We can continue to speculate or do our best diligence to figure out why.
Well LA, there is over 1.5 million up for sale from .0158-18. Here's your chance to load up cheap shares
Especially if we, as investors, can show a clear benefit to these people by deliberately keeping the stock in the toilet. Whether it a clear benefit in their IMUN position or a benefit in Their Cytocom position. At this point we need a paper trail and evidence to support our position.
And again LA, the question is Why? Why is a Lawyer, who knows nothing about what a PR should say, allowed to manipulate it into a bad PR which will drive PR away? Again is this all about a papertrail of deniability for everyone to attempt to point the finger at someone else? That may work one time, but allowing the Lawyer to mess with a PRs again and again with the same result of dropping stock price, and repeated investor complains, I do not think any person of reason would accept this as an "honest mistake" or a "I didn't know".
Every stock holder in this company, to include RJ understands the way the market works and what keeps value and retail trading to a stock. Noreen and Gina also know this.
I have stopped complaining about what needs to be done, because everyone knows what NEEDS to be done. The real question is WHY. Every investor needs to be asking that question. Every investor needs to start investigating tax documents, filings, communication, who are the investors, how many shares does Noreen and Gina own in this company and at what cost. Is there a benefit for the stock price being in the toilet. I personally have given Noreen many ideas for PRs along the way, as I know LA and others have. Why have they not been used? Again, find the benefit to anyone high up, or the legal team in keeping this stock in the toilet, and we as investors will have something to go on and pursue.
NO CEO WOULD CONTINUE TO DELIBERATELY SABOTAGE THEIR COMPANY, UNLESS THEY WERE TO BENEFIT.
SPARTANS the only question we all need to ask is why? And not just ask, dig, research, and prove why. We can sit by and just complain on this board (which is what Noreen and Legal would like us to do), or we can start investigating this company, and everyone involved and privately share our research until Noreen decides we are serious and gets the stock price trading where it is or we have enough stuff to go after them legally and hold them accountable, which on a public scale would not be goid for IMUN or Cytocom.
But, really, this is all on Noreen and Gina's head. They are the ones not releasing, or releasing horrible unreadable PRs. 2 people who have degrees and experience, will not be able to claim stupidity or lack of knowlege, as we can prove they have all these things.
I would have thought you would have understood by now: Noreen does not care about us investors. She and the Lawyer have some sort of agenda in keeping IMUN in the toilet. They are Deliberately not releasing news, and keeping Imun' s share price in the toilet. Every once in awhile, something is thrown out there, in an attempt to give them deniability for deliberately keeping the stock in the toilet. When we find out why, and if it is shady or even hints at anything illegal, they will be held accountable.
Not really hilarious, this is our stock being manipulated, and allowed to be Manipulated because of Noreen Griffen. Every other bio tech company out there does a good PR write up before a conference the scale of Amsterdam, and a great PR write up the first or second trading day after. Again, there is some shady shit going on. So much so, even Hopeful has stopped posting on this board. Hopeful must have some good inside information, he/she is refusing to share with the rest of us, even the usual, timely support of IMUN has diminished. For those of you still looking to load up, there is a bunch of shares up cheap.....or are the long holders becoming fearful also????
August 1st.....no news, no PR, nothing about the conference in Amsterdam? No CEO operates like this. Why is she still CEO? What dirt does Noreen hold over the board? Ridiculous
Reigns...dam* auto correct. Lol
Because Noreen is incompetent, clueless, and has no idea what it is to be a good CEO. It is time for the company to get an experienced, qualified CEO in place, we need a professional to take the rains, not a used car saleswoman.
Absolutely. And now, Cytocom is behind. Phase 3, not even started. Maybe it would be better to have a company like them buy us out, he'll even for matching shares! Lol. Noreen as president of Cytocom??? Lord help us, LDN may never see the light of day with the FDA.
Yes, but that doesn't stop her from funneling money through Cytocom, and paying herself that way. It is possible, she never said she wasn't being paid as the president of Cytocom.
Hopeful doesn't seem to respond to you these days Dwarren. Lol. Maybe hopeful is in tight with Noreen, and has a very healthy and cheap Cytocom position, and has been told to not make waves. Lol
Unfortunately I am not in a position to reinvest in Sugarmade at this time. I did 5 preffered paper stock purchases, and have a few more months to get them registered, and start trading them. If Sugarmade hasn't made the run by that time, I would definitely buy back in.
It begs the question: Since IMUN is funding Cytocom, and Cytocom is private, and Noreen is the president of Cytocom, is money going from IMUN into Cytocom, and Noreen being paid on the Cytocom side? If that were the case, her salary would still be paid by IMUN and it's investors. A shell game if sorts I would say, a little misdirection and word play if this were happening.